search
Back to results

Active You: A Novel Exercise Program for African Americans

Primary Purpose

Cardiovascular Risk Factor, Prediabetes, Overweight and Obesity

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
The Physical Activity for The Heart (PATH) intervention
Be Active Your Way Booklet
Sponsored by
University of Pittsburgh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Cardiovascular Risk Factor focused on measuring Physical activity, Web-based, YouTube, Remote

Eligibility Criteria

40 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. 40-70 years old
  2. BMI≥25
  3. Have regular access to the internet (via computer or smart phone)
  4. Less than 90 mins of self-reported moderate to vigorous physical activity per week
  5. American Diabetes Association (ADA) risk ≥5
  6. Available for pre and post-intervention assessments.
  7. Self-identify as Black/African American

Exclusion Criteria:

  1. Unstable conditions that may require supervised PA
  2. Physical limitations that may prohibit engagement in MVPA
  3. Pregnancy or intention to become pregnant during study, history of CVD
  4. Current participation in a PA study.

Sites / Locations

  • Primay Health Network
  • University of Pittsburgh

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

PATH Treatment Group

Wait-list control group

Arm Description

The PATH group will be granted password protected access to one of the 3 PATH levels based on their baseline fitness status. The intervention is designed to help participants increase their baseline PA via health coaching, self-monitoring and pragmatic workout videos that provide convenient options for overcoming socio-environmental barriers to PA.

Participants in this group will not have access to the PATH intervention until after 12 weeks when they cross over. After randomization, the control group will be provided with a copy of the Be Active Your Way booklet, developed by the Centers for Disease Control (CDC) to help individuals integrate PA in their daily lives.

Outcomes

Primary Outcome Measures

Recruitment feasibility
Will be indicated by ability to recruit, screen, and enroll the target sample within 6 months of commencing recruitment, and retention of ≥80% of the sample.
Feasibility of self-monitoring step count using wrist worn ActiGraph GT9X
will be indicated by the proportion of the sample with ≥4days per week of valid Actigraph wear time (≥10hrs) during the entire course of the study.
Acceptability of PATH intervention
Will be indicated by utilization data that will be collected via Web analytics, and a post-intervention survey will assess the intervention acceptability

Secondary Outcome Measures

Change from baseline in body mass index (BMI) at 12 weeks
BMI will be measured using Fitbit Aria II scale provided to the participant by the study team. The study team will guide the participants on how to measure their BMI and will supervise the measurement via HIPAA compliant Zoom session.
Change from baseline in body fat percentage at 12 weeks
Body fat percentage will be measured using Fitbit Aria II scale provided to the participant by the study team. The study team will guide the participants on how to measure their body fat and will supervise the measurement via HIPAA compliant Zoom session.
Change from baseline in waist circumference at 12 weeks
Waist circumference will be measured using Perfect waist tape measure provided to the participant by the study team. The study team will guide the participants on how to take the measurement using a standard video and will be able to observe the outcome of the measurement via HIPAA compliant Zoom session.
Change from baseline in blood pressure (BP) at 12 weeks
Both diastolic and systolic BP will be reported. The measurement will be done using automated OMRON BP machine provided to the participant by the study team. The study team will guide the participants on how to take blood pressure and will supervise the measurement via HIPAA compliant Zoom session.
Change from baseline in glycated hemoglobin (HbA1C) at 12 weeks
The sample for HbA1C will be collected by participants at home using the dry blood spot method. The study team will guide the participants on how to take the sample using a standard video and will supervise the collection via HIPAA compliant Zoom session. The sample will be processed by CoreMedica lab using standard protocols
Change from baseline in lipids at 12 weeks
The blood sample for lipids (LDL, HDL, and total cholesterol) will be collected by participants at home using the dry blood spot method. The study team will guide the participants on how to take the sample using a standard video and will supervise the collection via HIPAA compliant Zoom session. The sample will be processed by CoreMedica lab using standard protocols.
Change from baseline in the risk score for diabetes at 12 weeks
The risk score for diabetes will be measured via the American Diabetes Association (ADA) Risk Calculator. The scores range from 0 to 10 with higher scores indicating high risk for developing type 2 diabetes.
Change from baseline in step count at 12 weeks
Step count will be measured using a wrist worn ActiGraph GT9X link during the entire study period. The study outcomes will focus on change from baseline to 12 weeks
Change from baseline in light physical activity at 12 weeks
Light physical activity will be measured using a waist worn ActiGraph GT3X accelerometer
Change from baseline in moderate to vigorous physical activity (MVPA) at 12 weeks
MVPA will be measured using a waist worn ActiGraph GT3X accelerometer
Change from baseline in Barriers Exercise Self-efficacy (BARSE) scale at 12 weeks
Participants will be asked to respond to the BARSE scale appraising their exercise self-efficacy. The scale range from 0 to 100, with higher scores indicating increased exercise self-efficacy

Full Information

First Posted
February 19, 2020
Last Updated
October 6, 2022
Sponsor
University of Pittsburgh
Collaborators
National Center for Advancing Translational Sciences (NCATS)
search

1. Study Identification

Unique Protocol Identification Number
NCT04280783
Brief Title
Active You: A Novel Exercise Program for African Americans
Official Title
Feasibility and Acceptability of a Web-based Physical Activity for the Heart (PATH) Intervention Designed to Reduce the Risk of Heart Disease Among Inactive African Americans
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Completed
Study Start Date
October 27, 2020 (Actual)
Primary Completion Date
December 31, 2021 (Actual)
Study Completion Date
December 31, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pittsburgh
Collaborators
National Center for Advancing Translational Sciences (NCATS)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Barriers to physical activity (PA) among African Americans (AAs) have been extensively studied, yet there is a paucity of innovative PA interventions designed to address them. In recent years, many studies have used the internet to promote PA in many settings, including the home environment, but only a few studies have recruited AAs. Without innovative and culturally relevant interventions, AAs will continue reporting extremely low levels of PA and disparate cardiovascular health outcomes. In prior work, the investigators sought the input of AA focus groups to inform the development of a technology-based Physical Activity for The Heart (PATH) intervention that leverages openly accessible platforms, such as YouTube, to promote PA in any setting. The investigators designed PATH as a culturally salient action-oriented intervention that can be accessed in any setting to promote PA among inactive AAs. In this application, the investigators propose to examine whether PATH is a feasible strategy for promoting PA among inactive AAs. In Aim 1 the investigators will conduct a randomized clinical trial that will include 30 inactive AAs to assess the feasibility and acceptability of the PATH intervention. In Aim 2 the investigators will examine the trend in PA and cardiovascular disease risk change from baseline to post-intervention. This approach is innovative because it leverages openly accessible technologies to provide a wide variety of free, enjoyable and action-oriented workout videos that match AAs preferences. This contribution will be significant because PATH could offer a novel, low-cost, and scalable strategy for promoting PA among individuals facing socio-environmental barriers to PA.
Detailed Description
Whereas an inverse dose-response relationship has been established between physical activity (PA) and a host of chronic illnesses, including cardiovascular disease (CVD), most American adults (79%) are physically inactive and do not attain the minimum PA levels recommended by the PA Guidelines for Americans. African Americans (AAs) in particular report very low levels of PA, and have the highest burden of CVD in the United States.To eliminate the prevailing cardiovascular health disparities, there is a critical need for pragmatic and culturally salient interventions that are designed to address barriers to PA that are more problematic for AAs. Common barriers to PA such as lack of time and low exercise self-efficacy are pervasive in all racial groups. In addition to these barriers, socio-environmental factors, such as unsafe neighborhoods and limited access to fitness facilities play a key role in perpetuating the low levels of PA observed in AAs. To mitigate these barriers, home-based PA interventions delivered via mail, telephone and internet have been developed. Although only a few of these interventions have been tested among AAs, preliminary studies have reported more participation and retention of AAs in home-based PA programs. However, the associated PA outcomes have been minimal, especially in less educated AAs. Low literacy levels and reliance on print-based resources with no cultural appeal are thought to limit the utility of the interventions in AAs. The investigators have previously reported how AAs prefer PA programs that are visual, convenient, fun to engage in, and feature people they can relate to especially in body size, fitness status and age. Other studies have reported similar preferences for PA among AAs, yet there is a paucity of PA interventions that are designed to incorporate these preferences. To bridge this gap, the investigators have developed a web-based Physical Activity for The Heart (PATH) intervention that leverages openly accessible platforms, such as YouTube, to proffer workout videos that match the reported preferences. Currently, PATH includes 90 workout videos vetted using the FITT principle (frequency, intensity, time, type) and curated on the PATH website in 3 controlled levels of intensity (beginner, intermediate, proficient) to foster gradual progression from low to high intensity PA. The overarching aim of the proposed study is to conduct a pilot randomized controlled trial (RCT) to assess the feasibility and acceptability of the PATH intervention for promoting PA in AAs. The investigators will enroll 30 inactive AAs and randomize them to either treatment (12-wks of PATH) or wait-list control (use a general health handout) group to address the following specific aims: Aim 1: Assess the feasibility and acceptability of the PATH intervention among inactive AAs. Feasibility will be assessed via 1) number of participants screened for eligibility; 2) percentage eligible; 3) percentage enrolled; 4) percentage retained within each randomized group; and 5) adherence to self-monitoring (Actigraph wear time) and intervention protocol (PATH utilization). Acceptability will be evaluated via a post-intervention survey developed by the study team to appraise the intervention's usability and perceived efficacy for increasing PA. Aim 2: Describe the trends in PA and CVD risk change from baseline to post-intervention. The primary outcome will be PA and will include objectively measured steps, light PA, and moderate-to-vigorous PA (MVPA). Cardiovascular outcomes will include blood pressure (BP), body fat percentage, body mass index (BMI), glycated hemoglobin (HbA1c) and lipids (LDL, HDL, and total cholesterol). Trends will be summarized as mean within-group changes (with 95% confidence intervals [CIs]). The proposed research addresses a key driver of cardiovascular health disparities and is innovative in its rigorous testing of the novel PATH intervention for feasibility and acceptability among inactive AAs. Findings from this study will inform the refinement of the PATH intervention to be tested in a full-scale RCT.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Risk Factor, Prediabetes, Overweight and Obesity, Sedentary Behavior
Keywords
Physical activity, Web-based, YouTube, Remote

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
We will randomize 30 participants to either the PATH treatment group or wait-list control group.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
PATH Treatment Group
Arm Type
Experimental
Arm Description
The PATH group will be granted password protected access to one of the 3 PATH levels based on their baseline fitness status. The intervention is designed to help participants increase their baseline PA via health coaching, self-monitoring and pragmatic workout videos that provide convenient options for overcoming socio-environmental barriers to PA.
Arm Title
Wait-list control group
Arm Type
Other
Arm Description
Participants in this group will not have access to the PATH intervention until after 12 weeks when they cross over. After randomization, the control group will be provided with a copy of the Be Active Your Way booklet, developed by the Centers for Disease Control (CDC) to help individuals integrate PA in their daily lives.
Intervention Type
Behavioral
Intervention Name(s)
The Physical Activity for The Heart (PATH) intervention
Intervention Description
The web-based Physical Activity for The Heart (PATH) intervention leverages openly accessible platforms, such as YouTube, to proffer workout videos that match the participants preferences. Currently, PATH includes over 90 workout videos vetted by a team of experts and curated on the PATH website in 3 controlled levels of intensity (beginner, intermediate, proficient) to foster gradual progression from low to high intensity PA in accordance with the FITT-VP (frequency, intensity, time, type, volume, progression) principle.
Intervention Type
Behavioral
Intervention Name(s)
Be Active Your Way Booklet
Intervention Description
Be Active Your Way booklet was developed by the Centers for Disease Control (CDC) to help individuals integrate PA in their daily lives. It simply encourages individuals to increase their PA gradually and gives them examples of things that they can do.
Primary Outcome Measure Information:
Title
Recruitment feasibility
Description
Will be indicated by ability to recruit, screen, and enroll the target sample within 6 months of commencing recruitment, and retention of ≥80% of the sample.
Time Frame
At the end of study approximately 48 weeks after commencement of the study
Title
Feasibility of self-monitoring step count using wrist worn ActiGraph GT9X
Description
will be indicated by the proportion of the sample with ≥4days per week of valid Actigraph wear time (≥10hrs) during the entire course of the study.
Time Frame
At the end of study approximately 52 weeks after commencement of the study
Title
Acceptability of PATH intervention
Description
Will be indicated by utilization data that will be collected via Web analytics, and a post-intervention survey will assess the intervention acceptability
Time Frame
At the end of study approximately 52 weeks after commencement of the study
Secondary Outcome Measure Information:
Title
Change from baseline in body mass index (BMI) at 12 weeks
Description
BMI will be measured using Fitbit Aria II scale provided to the participant by the study team. The study team will guide the participants on how to measure their BMI and will supervise the measurement via HIPAA compliant Zoom session.
Time Frame
Post-intervention at 12 weeks
Title
Change from baseline in body fat percentage at 12 weeks
Description
Body fat percentage will be measured using Fitbit Aria II scale provided to the participant by the study team. The study team will guide the participants on how to measure their body fat and will supervise the measurement via HIPAA compliant Zoom session.
Time Frame
Post-intervention at 12 weeks
Title
Change from baseline in waist circumference at 12 weeks
Description
Waist circumference will be measured using Perfect waist tape measure provided to the participant by the study team. The study team will guide the participants on how to take the measurement using a standard video and will be able to observe the outcome of the measurement via HIPAA compliant Zoom session.
Time Frame
Post-intervention at 12 weeks
Title
Change from baseline in blood pressure (BP) at 12 weeks
Description
Both diastolic and systolic BP will be reported. The measurement will be done using automated OMRON BP machine provided to the participant by the study team. The study team will guide the participants on how to take blood pressure and will supervise the measurement via HIPAA compliant Zoom session.
Time Frame
Post-intervention at 12 weeks
Title
Change from baseline in glycated hemoglobin (HbA1C) at 12 weeks
Description
The sample for HbA1C will be collected by participants at home using the dry blood spot method. The study team will guide the participants on how to take the sample using a standard video and will supervise the collection via HIPAA compliant Zoom session. The sample will be processed by CoreMedica lab using standard protocols
Time Frame
Post-intervention at 12 weeks
Title
Change from baseline in lipids at 12 weeks
Description
The blood sample for lipids (LDL, HDL, and total cholesterol) will be collected by participants at home using the dry blood spot method. The study team will guide the participants on how to take the sample using a standard video and will supervise the collection via HIPAA compliant Zoom session. The sample will be processed by CoreMedica lab using standard protocols.
Time Frame
Post-intervention at 12 weeks
Title
Change from baseline in the risk score for diabetes at 12 weeks
Description
The risk score for diabetes will be measured via the American Diabetes Association (ADA) Risk Calculator. The scores range from 0 to 10 with higher scores indicating high risk for developing type 2 diabetes.
Time Frame
Post-intervention at 12 weeks
Title
Change from baseline in step count at 12 weeks
Description
Step count will be measured using a wrist worn ActiGraph GT9X link during the entire study period. The study outcomes will focus on change from baseline to 12 weeks
Time Frame
Post-intervention at 12 weeks
Title
Change from baseline in light physical activity at 12 weeks
Description
Light physical activity will be measured using a waist worn ActiGraph GT3X accelerometer
Time Frame
Post-intervention at 12 weeks
Title
Change from baseline in moderate to vigorous physical activity (MVPA) at 12 weeks
Description
MVPA will be measured using a waist worn ActiGraph GT3X accelerometer
Time Frame
Post-intervention at 12 weeks
Title
Change from baseline in Barriers Exercise Self-efficacy (BARSE) scale at 12 weeks
Description
Participants will be asked to respond to the BARSE scale appraising their exercise self-efficacy. The scale range from 0 to 100, with higher scores indicating increased exercise self-efficacy
Time Frame
Post-intervention at 12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 40-70 years old BMI≥25 Have regular access to the internet (via computer or smart phone) Less than 90 mins of self-reported moderate to vigorous physical activity per week American Diabetes Association (ADA) risk ≥5 Available for pre and post-intervention assessments. Self-identify as Black/African American Exclusion Criteria: Unstable conditions that may require supervised PA Physical limitations that may prohibit engagement in MVPA Pregnancy or intention to become pregnant during study, history of CVD Current participation in a PA study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jacob Kariuki, PhD
Organizational Affiliation
University of Pittsburgh
Official's Role
Principal Investigator
Facility Information:
Facility Name
Primay Health Network
City
Beaver Falls
State/Province
Pennsylvania
ZIP/Postal Code
15010
Country
United States
Facility Name
University of Pittsburgh
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15261
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
It is our goal to make all data generated from this proposal available to other investigators without compromising the confidentiality of participants. Investigators who would like to do a secondary analysis of de-identified data can submit a formal request for the data including the proposal of their intended analysis to the PI at activeu@pitt.edu. The PI will review all requests and facilitate data access once approval is granted.
IPD Sharing Time Frame
12 months after the end of the study
IPD Sharing Access Criteria
Data access will be provided based on scientific merit of the proposed analysis, IRB approval and data agreement contract as deemed appropriate by University of Pittsburgh

Learn more about this trial

Active You: A Novel Exercise Program for African Americans

We'll reach out to this number within 24 hrs